Zurich Cantonal Bank’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $843K | Buy |
29,667
+3,776
| +15% | +$107K | ﹤0.01% | 1327 |
|
|
2025
Q1 | $764K | Sell |
25,891
-1,568
| -6% | -$46.3K | ﹤0.01% | 1336 |
|
|
2024
Q4 | $799K | Buy |
27,459
+6,089
| +28% | +$177K | ﹤0.01% | 1333 |
|
|
2024
Q3 | $982K | Sell |
21,370
-907
| -4% | -$41.7K | ﹤0.01% | 1135 |
|
|
2024
Q2 | $910K | Buy |
22,277
+7,258
| +48% | +$296K | ﹤0.01% | 1117 |
|
|
2024
Q1 | $383K | Buy |
15,019
+3,551
| +31% | +$90.6K | ﹤0.01% | 1646 |
|
|
2023
Q4 | $104K | Sell |
11,468
-182
| -2% | -$1.65K | ﹤0.01% | 2435 |
|
|
2023
Q3 | $74.3K | Sell |
11,650
-126
| -1% | -$804 | ﹤0.01% | 2486 |
|
|
2023
Q2 | $131K | Buy |
11,776
+1,604
| +16% | +$17.8K | ﹤0.01% | 2199 |
|
|
2023
Q1 | $156K | Buy |
10,172
+136
| +1% | +$2.09K | ﹤0.01% | 2033 |
|
|
2022
Q4 | $223K | Buy |
10,036
+4,654
| +86% | +$103K | ﹤0.01% | 1757 |
|
|
2022
Q3 | $88K | Hold |
5,382
| – | – | ﹤0.01% | 2325 |
|
|
2022
Q2 | $78K | Sell |
5,382
-100
| -2% | -$1.45K | ﹤0.01% | 2407 |
|
|
2022
Q1 | $101K | Buy |
5,482
+1,304
| +31% | +$24K | ﹤0.01% | 2286 |
|
|
2021
Q4 | $99K | Hold |
4,178
| – | – | ﹤0.01% | 2515 |
|
|
2021
Q3 | $103K | Buy |
+4,178
| New | +$103K | ﹤0.01% | 2322 |
|